Adaptin Bio APTN
OTC APTN
$6.27 +0.00 (+0.00%)
At close: Aug 19, 2026 · 4:00 PM EDT

Adaptin Bio (APTN) Share-based Compensation (2025 - 2026)

Updated

Adaptin Bio (APTN) posted Share-based Compensation of $193,806 for Q2 2026, down 43.9% from the prior quarter.

Analysis

Adaptin Bio (APTN) Share-based Compensation (2025 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Share-based Compensation at Adaptin Bio was $1.31 million; for FY2025, it came in at $1.02 million.

  • Quarterly Share-based Compensation has run from a low of -$75,000 in Q4 2025 to a high of $845,000 in Q3 2025 over five years.
  • According to Business Quant data, Share-based Compensation for the three prior quarters was $345,396 (Q1 2026), -$75,000 (Q4 2025) and $845,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 458.00 Mn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 166.00 Mn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 298.00 Mn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 165.00 Mn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 231.00 Mn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 249.00 Mn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 170.20 Mn
10 Adaptin Bio 56.76 Mn 54.75 Mn - 193,806.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 193,806.00
Mar 31, 2026 345,396.00
Dec 31, 2025 -75,000.00
Sep 30, 2025 845,000.00
API Access

Adaptin Bio Share-based Compensation API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=share-based-compensation&ticker=APTN&period=max&api_key=YOUR_API_KEY